Thank you for your interest

Listen to the Podcast below or view a Transcript of the Podcast here

Small Molecule Ubiquitin Protease (USP7) Inhibitors with Immune Cell Based Anti-Tumor Activity Superior to that of Biologicals

Tauseef R. Butt, Ph.D., President and CEO, Progenra, Inc.

Tauseef Butt, CEO of Progenra Inc. speaks to CHI on September 8, 2017. Dr. Butt will be presenting during Immunomodulatory Small Molecules and Targeting the Ubiquitin Proteasome System, taking place this September 27-28 at Discovery on Target in Boston, MA.

Topics include the benefits and challenges of immunomodulatory small molecules, Ubiquitin Protease (USP7) Inhibitors performance in animal models, Progenra’s discovery platform and their plans for developing other immunomodulatory strategies.

For more information, please visit www.DiscoveryOnTarget.com/Immunomodulatory-Small-Molecules/ and www.DiscoveryOnTarget.com/Ubiquitin-Proteasome/